Mueser K T, Doonan R, Penn D L, Blanchard J J, Bellack A S, Nishith P, DeLeon J
Medical College of Pennsylvania at Eastern Pennsylvania Psychiatric Institute, Philadelphia, USA.
J Abnorm Psychol. 1996 May;105(2):271-5. doi: 10.1037//0021-843x.105.2.271.
This study evaluated (a) whether chronic, medicated schizophrenia patients show deficits in emotion recognition compared to nonpatients, and (b) whether deficits in emotion recognition are related to poorer social competence. Two emotion recognition tests developed by S. L. Kerr and J. M. Neale (1993) and Benton's Test of Facial Recognition (A. Benton, M. VanAllen, K. Hamsher, & H. Levin, 1978) were given to patients with chronic schizophrenia and nonpatient controls. Patients' social skills, social adjustment, and symptomatology were assessed. Like Kerr and Neale's unmedicated patients, these patients performed worse than controls on both emotion recognition tests and the control test. For patients, facial perception was related to the chronicity of illness and social competence. Chronicity of illness may contribute to face perception deficits in schizophrenia, which may affect social competence.
（a）与非患者相比，慢性药物治疗的精神分裂症患者在情绪识别方面是否存在缺陷；以及（b）情绪识别缺陷是否与较差的社交能力相关。S. L. 克尔和J. M. 尼尔（1993年）开发的两项情绪识别测试以及本顿面部识别测试（A. 本顿、M. 范艾伦、K. 哈姆舍尔和H. 莱文，1978年）被用于慢性精神分裂症患者和非患者对照组。对患者的社交技能、社会适应和症状进行了评估。与克尔和尼尔的未接受药物治疗的患者一样，这些患者在两项情绪识别测试和对照测试中的表现均比对照组差。对于患者而言，面部感知与疾病的慢性程度和社交能力相关。疾病的慢性程度可能导致精神分裂症患者面部感知缺陷，这可能会影响社交能力。
